Filed with the SEC on · accession 0001213900-26-117180
TTRX filed a 8-K (current report) with the SEC on Nov 9, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Turn Therapeutics Inc. furnished a Form 8-K announcing its financial and operating results for the quarter ended September 30, 2026, via a press release attached as Exhibit 99.1.
✦ Ask GOAX AI about this filing — what it means for TTRX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TTRX?
Click hereTTRX filed a 8-K (SEC filing). Turn Therapeutics Inc. furnished a Form 8-K announcing its financial and operating results for the quarter ended September 30, 2026, via a press release attached as Exhibit 99.1.
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Get alerts when TTRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days